Showing posts with label MAT. Show all posts
Showing posts with label MAT. Show all posts

Tuesday, December 15, 2009

Medication-Assisted Treatment in West Virginia

Advancing Recovery grantee Prestera Center is removing barriers to the implementation of medication-assisted treatment. Read the full article.

Tuesday, December 1, 2009

Medication-assisted Treatment at Prestera Center

Prestera Center, a NIATx agency participating in the Advancing Recovery initiative, was recently featured in Huntington (WV) Herald-Dispatch in a story about their successful implementation of medication-assisted treatment.

Monday, November 2, 2009

MAT Interest Circle Call with Dr. David Prescott

Please join us for the next Medication-assisted Treatment (MAT) interest circle call, presented by Dr. David Prescott.

Improving Access to MAT by Decreasing Time from Admission to Treatment and Expanding the use of MAT with Alcohol Dependency.
Tuesday, November 3, 12 pm Eastern (11am Central, 10am Mountain, 9am Pacific)

To join this interest circle call:
  1. Dial 1-866-642-1665.
  2. Enter this passcode: 759636#.
Dr. David Prescott is the Director for Clinical Research at Acadia Hospital. His research interests include the integration of primary medical care and behavioral health care, reducing the use of restraints in behavioral health treatment, and applications of rapid-cycle performance improvement in addiction treatment.

Wednesday, October 28, 2009

ARWV: Removing Barriers to the Use of MAT

Advancing Recovery West Virginia (ARWV): removing barriers to the use of medication-assisted treatment for opioid dependence.

Through their Advancing Recovery partnership, Prestera Center for Mental Health Services, Seneca Health Services, Westbrook Health Services and Valley HealthCare System, are working with the West Virginia Division on Alcohol and Drug Abuse to improve addiction treatment services in the state.

Collectively, the four partnering agencies provide substance abuse services to over 40 percent of the counties in West Virginia and to 49 percent of the population of the state. In the first 12 months of their collaboration, ARWV increased the use of buprenorphine for opioid dependence by 102 percent.